Victor Hong

Victor Hong has extensive experience in the pharmaceutical industry. Victor is currently serving as the VP Finance at Fate Therapeutics Inc. From 2019 to 2021, Victor held the position of Vice President, WW Hematology Strategy at Bristol Myers Squibb. Prior to that, from 2012 to 2019, they worked as the Executive Director in Business Planning, Finance, and Forecasting at Celgene. Victor also worked at Novartis as an Associate Director in Marketing Science from 2006 to 2012, and at Pfizer as a Manager in Statistics & Programming, Clinical Development from 2001 to 2006. Victor began their career as a Contractor in Clinical Data Management at Smith Hanley Associates in 2001.

Victor Hong completed their Bachelor of Science degree in Biomedical Engineering from Boston University between 1991 and 1995. Victor then pursued a Masters in Biostatistics from Columbia University Mailman School of Public Health from 1999 to 2001. Later, they obtained their MBA with a specialization in Marketing from Fordham Gabelli School of Business from 2002 to 2005.